Results 11 to 20 of about 887,744 (175)

Self-Assembly of Antigenic Peptide Nanofibrils Templates the Growth of Silica Nanoparticles for Nanovaccines. [PDF]

open access: yesAdv Sci (Weinh)
Antigenic peptides Aβ42 and E7 self‐assemble into nanofibrils; APTES and TEOS induce SiO2 NP formation on these fibrils to form SiO2@fibril nanovaccines, which activate BMDCs in vitro. In vivo, SiO2@Aβ42 fibril nanovaccines alleviate AD symptoms and clear Aβ42 plaques in APP/PS1 mice, and SiO2@E7 fibril nanovaccines inhibit tumor growth and promote ...
Yang X   +6 more
europepmc   +2 more sources

The vaginal microbiome, papillomavirus infection, and cervical cancer: established associations in search of model systems and mechanistic answers [PDF]

open access: yesmBio
High-risk human papillomavirus (HPV) infection is the causative factor for approximately 5% of all human cancers and the leading cause of cervical cancer. High-risk HPV-associated cervical cancer still claims more than 340,000 women’s lives globally each
Gianna V. Passarelli   +3 more
doaj   +2 more sources

A mouse model of HPV-associated cervicovaginal carcinosarcoma with comparative analysis to human clinical cases [PDF]

open access: yesCell & Bioscience
Background Carcinosarcomas of the gynecologic tract, previously referred to as malignant mixed müllerian/mesodermal tumor, are devastating malignancies that remain poorly studied due to their rarity and the lack of relevant model systems.
Jason Murray   +4 more
doaj   +2 more sources

Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1) [PDF]

open access: yesJournal of Virological Methods, 2018
Paul Lambert, Aayushi Uberoi
exaly   +2 more sources

Compromised T Cell Immunity Links Increased Cutaneous Papillomavirus Activity to Squamous Cell Carcinoma Risk

open access: yesJID Innovations, 2023
Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer, with increased incidence in immunosuppressed patients. β-Human papillomavirus has been proposed as a contributor to cSCC risk partly on the basis of increased β-human ...
Luke H. Johnson   +5 more
doaj   +1 more source

Immune Responses in Oral Papillomavirus Clearance in the MmuPV1 Mouse Model

open access: yesPathogens, 2023
Human papillomavirus (HPV)-induced oropharyngeal cancer now exceeds HPV-induced cervical cancer, with a noticeable sex bias. Although it is well established that women have a more proficient immune system, it remains unclear whether immune control of ...
Sarah A. Brendle   +10 more
doaj   +1 more source

Cryo EM Analysis Reveals Inherent Flexibility of Authentic Murine Papillomavirus Capsids

open access: yesViruses, 2021
Human papillomavirus (HPV) is a significant health burden and leading cause of virus-induced cancers. However, studies have been hampered due to restricted tropism that makes production and purification of high titer virus problematic.
Samantha R. Hartmann   +6 more
doaj   +1 more source

MmuPV1-Induced Cutaneous Squamous Cell Carcinoma Arises Preferentially from Lgr5+ Epithelial Progenitor Cells

open access: yesViruses, 2022
Murine papillomavirus, MmuPV1, causes natural infections in laboratory mice that can progress to squamous cell carcinoma (SCC) making it a useful preclinical model to study the role of papillomaviruses in cancer.
Ruben Moreno   +2 more
doaj   +1 more source

A novel lineage-tracing mouse model for studying early MmuPV1 infections

open access: yeseLife, 2022
Human papillomaviruses are DNA viruses that ubiquitously infect humans and have been associated with hyperproliferative lesions. The recently discovered mouse specific papillomavirus (MmuPV1) provides the opportunity to study papillomavirus infections in
Vural Yilmaz   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy